https://www.business-standard.com/article/companies/bharat-biotech-to-begin-trials-of-intranasal-vaccine-for-covid-in-feb-mar-121010800340_1.html
The Phase-1 trials will be conducted in Saint Louis University’s Vaccine and Treatment Evaluation Unit
Bharat Biotech to begin trials of intranasal vaccine for Covid in Feb-Mar
Published in Business and Uncategorized
More from BusinessMore posts in Business »
- Bitcoin Still Far From A True Supply Shock, Analyst Explains
- Dogecoin (DOGE) Fights to Stay Afloat — Major Hurdles Remain
- North Carolina Passes Bill To Integrate Bitcoin Into $127 Billion Pension Fund
- US Could Buy $100 Billion In Bitcoin This Year: Coinbase Exec
- XRP Price Needs $2.25 Flip — Bulls Prepping for Fresh Momentum
- Trader Joe’s has a delicious copycat of a Chipotle favorite
- Surprising earnings send Meta Platforms stock soaring
- Popular Tex-Mex chain’s newest cocktail has fans swooning
- Surprising Microsoft earnings sends stock surging
- Veteran fund manager reboots Palantir stock price target ahead of earnings
More from UncategorizedMore posts in Uncategorized »
- Bitcoin Still Far From A True Supply Shock, Analyst Explains
- Dogecoin (DOGE) Fights to Stay Afloat — Major Hurdles Remain
- North Carolina Passes Bill To Integrate Bitcoin Into $127 Billion Pension Fund
- US Could Buy $100 Billion In Bitcoin This Year: Coinbase Exec
- XRP Price Needs $2.25 Flip — Bulls Prepping for Fresh Momentum
- Trader Joe’s has a delicious copycat of a Chipotle favorite
- Surprising earnings send Meta Platforms stock soaring
- Popular Tex-Mex chain’s newest cocktail has fans swooning
- Surprising Microsoft earnings sends stock surging
- Veteran fund manager reboots Palantir stock price target ahead of earnings